Function
Locations
First committed step of sterol biosynthesis; diverts the isoprenoid pool specifically to sterols. Deficiency = squalene synthase deficiency.
The sterol-commitment segment of cholesterol biosynthesis converts the isoprenoid intermediate farnesyl diphosphate into the first cyclic sterol, lanosterol, committing carbon away from the branched isoprenoid pool (dolichol, ubiquinone, prenylation) and irreversibly toward sterols. Squalene synthase (FDFT1) performs the first committed step: a reductive head-to-head condensation of two farnesyl-diphosphate molecules (via presqualene diphosphate) to the C30 hydrocarbon squalene. Squalene monooxygenase / epoxidase (SQLE), an FAD flavoprotein and the second rate-limiting, cholesterol-feedback- regulated enzyme of the pathway, oxidises squalene to (S)-2,3-epoxysqualene using O2 and NADPH. Lanosterol synthase (LSS, oxidosqualene cyclase) then carries out the remarkable polycyclization of 2,3-epoxysqualene to lanosterol, the tetracyclic sterol scaffold from which cholesterol (and, in other tissues, downstream sterols) is made by the post-lanosterol demethylation/reduction steps. All three enzymes are endoplasmic-reticulum-membrane proteins. Inherited defects: FDFT1 deficiency (squalene synthase deficiency, a congenital cholesterol-biosynthesis disorder with dysmorphism/developmental delay) and LSS mutations (hypotrichosis with juvenile cataract / congenital cataract, and a palmoplantar keratoderma); SQLE is a validated antifungal/anticancer drug target rather than a Mendelian-disease gene.
All recommended fields populated.
✗ none found
No MODULE:sterol_commitment_squalene_to_lanosterol deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
3 gene-function check(s) reflected in core functions · 0 conflict(s) · 3 evidence or coverage gap(s) (6 comparison(s))
Retained noncore functions are reported separately; they do not require promotion to core functions. Support from representative genes does not establish conservation across the whole family. Missing reviews or identifiers leave a claim unverified.
| Annoton | Participant | Function | Assessment |
|---|---|---|---|
| fdft1_activity | FDFT1 (human) UniProtKB:P37268 Family Representative |
squalene synthase [NAD(P)H] activity GO:0051996 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| sqle_activity | SQLE (human) UniProtKB:Q14534 Family Representative |
squalene monooxygenase activity GO:0004506 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| lss_activity | LSS (human) UniProtKB:P48449 Family Representative |
lanosterol synthase activity GO:0000250 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| fdft1_activity | Squalene/phytoene synthase family (FDFT1) PANTHER:PTHR11626 Family |
squalene synthase [NAD(P)H] activity GO:0051996 |
Family Scope Restricted
GO:0051996 is SUBFAMILY_ONLY; this family grounding does not establish the allowed subfamily scope. The modules (ergosterol_biosynthesis and sterol_commitment_squalene_to_lanosterol) select the base family for this activity. Not safe family-wide, because SF3 (Arabidopsis SQS2) is inactive. Within SF2 it holds for the canonical single-copy fungal, animal and plant enzymes. The Botryococcus SSL-1, SSL-2 and SSL-3 each carry out only part of the reaction or make a different product, so they are listed as member exceptions. |
| sqle_activity | Squalene monooxygenase family (SQLE) PANTHER:PTHR10835 Family |
squalene monooxygenase activity GO:0004506 |
Family Scope Restricted
GO:0004506 is SUBFAMILY_ONLY; this family grounding does not establish the allowed subfamily scope. SF0, as ergosterol_biosynthesis selects; accepted by ERG1, erg1, SQLE and rat Sqle. sterol_commitment_squalene_to_lanosterol uses the base family, which also takes in the unassessed plant paralogs. |
| lss_activity | Oxidosqualene cyclase family (LSS) PANTHER:PTHR11764 Family |
lanosterol synthase activity GO:0000250 |
Family Scope Restricted
GO:0000250 is SUBFAMILY_ONLY; this family grounding does not establish the allowed subfamily scope. SF20, as ergosterol_biosynthesis selects; sterol_commitment_squalene_to_lanosterol uses the base family. S. japonicus shc1 in SF20 is a squalene-hopene cyclase and is listed as an exception. |
3 complete review(s) · 0 with deep research · 0 missing review · 3 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| FDFT1 P37268 | ✓ | ✓ | ✗ |
| LSS P48449 | ✓ | ✓ | ✗ |
| SQLE Q14534 | ✓ | ✓ | ✗ |
The sterol-commitment (squalene -> lanosterol) segment of cholesterol biosynthesis grounded to the human enzymes FDFT1 (UniProtKB:P37268, GO:0051996, EC 2.5.1.21), SQLE (Q14534, GO:0004506, EC 1.14.14.17) and LSS (P48449, GO:0000250, EC 5.4.99.7). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each step uses a PANTHER family selector with the human enzyme as representative; all three enzymes reside in the ER membrane. Upstream, farnesyl diphosphate comes from the mevalonate pathway (HMGCS1/HMGCR/ MVK/PMVK/MVD -> IPP -> FDPS); downstream, lanosterol is converted to cholesterol by the post-lanosterol demethylation/reduction enzymes (CYP51A1, TM7SF2/LBR, MSMO1, NSDHL, HSD17B7, EBP, SC5D, DHCR7/DHCR24) via the Bloch and Kandutsch-Russell arms (a separate module, to follow). FDFT1 is the committed branch point diverting the shared isoprenoid pool to sterols; SQLE is the second cholesterol-feedback-regulated rate-limiting control point. Disorders: FDFT1 -> squalene synthase deficiency; LSS -> hypotrichosis with juvenile cataract / congenital cataract (and a palmoplantar keratoderma); SQLE is a drug target (terbinafine-class antifungals; anticancer) rather than a classic disease gene.
First committed step of sterol biosynthesis; diverts the isoprenoid pool specifically to sterols. Deficiency = squalene synthase deficiency.
FAD-dependent epoxidation of squalene; second rate-limiting step, subject to cholesterol-accelerated degradation. Antifungal/anticancer drug target.
Cyclises 2,3-epoxysqualene to lanosterol, the tetracyclic sterol scaffold and committed precursor of cholesterol. Mutations -> congenital cataract / hypotrichosis.